In the future, our further research will be focused on verifying the effect of ASPP2-mTORC1-ERS axis on hepatocyte apoptosis and autophagy through animal experiments, which would contribute to identifying a new target for the treatment of liver injury and liver failure. This evidence concerns the gene TP53BP2 and liver failure.